We are live on ! Find out more
ACIU icon

AC Immune
ACIU

32 hedge funds and large institutions have $153M invested in AC Immune in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,700% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 1

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

113% more funds holding

Funds holding: 15 → 32 (+17)

50% more capital invested

Capital invested by funds: $102M → $153M (+$50.8M)

9.26% more ownership

Funds ownership: 19.15% → 28.41% (+9.3%)

Holders
32
Holders Change
+17
Holders Change %
+113.33%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$20.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$16.8M
3
O
OrbiMed
New York
+$14.5M
4
Temasek Holdings
Temasek Holdings
Singapore
+$12.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.7M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$11.9M
2
PC
PointState Capital
New York
-$4.39M
3
LBC
Lawrence B. Cohen
-$57.3K
4
EDRH
Edmond de Rothschild Holding
Switzerland
-$3.37K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$41.7M +$11.7M +1,166,524 +29%
Temasek Holdings
2
Temasek Holdings
Singapore
$20.9M +$12.8M +1,276,595 +95%
DFO
3
Duquesne Family Office
New York
$19.9M +$1.03M +102,817 +4%
BI
4
BVF Inc
California
$16.1M +$20.3M +2,017,500 New
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$13.3M +$16.8M +1,668,177 New
O
6
OrbiMed
New York
$11.5M +$14.5M +1,440,000 New
AG
7
Artal Group
Luxembourg
$6M +$1.51M +150,000 +25%
PC
8
PointState Capital
New York
$4.51M -$4.39M -436,150 -44%
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$4.38M +$5.24M +520,953 +1,996%
SFM
10
Sphera Funds Management
Israel
$4.03M +$5.06M +503,563 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$3.04M +$3.81M +379,400 New
Citadel Advisors
12
Citadel Advisors
Florida
$2.28M +$2.86M +284,837 New
TCM
13
Tekla Capital Management
Massachusetts
$1.38M – – –
State of New Jersey Common Pension Fund D
14
State of New Jersey Common Pension Fund D
New Jersey
$626K +$786K +78,207 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$427K +$20.6K +2,047 +4%
Renaissance Technologies
16
Renaissance Technologies
New York
$418K +$299K +29,720 +132%
BAM
17
Belpointe Asset Management
Nevada
$400K +$503K +50,000 New
BFM
18
Boothbay Fund Management
New York
$320K +$402K +39,960 New
CLOS
19
Compagnie Lombard Odier SCmA
Switzerland
$268K +$302K +30,039 +858%
State Street
20
State Street
Massachusetts
$250K +$315K +31,300 New
Morgan Stanley
21
Morgan Stanley
New York
$247K +$18.1K +1,801 +6%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$173K +$218K +21,644 New
Deutsche Bank
23
Deutsche Bank
Germany
$168K +$88.9K +8,846 +73%
JP Morgan Chase
24
JP Morgan Chase
New York
$142K +$179K +17,803 New
TD Asset Management
25
TD Asset Management
Ontario, Canada
$140K +$176K +17,506 New
1
2

ACIU Hedge Fund Activity: Q3 2018 in Review

32 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2018, worth a combined $153M — up 50% from $102M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ACIU positions and 1 closed out — a net gain of 17 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $20.3M. The largest seller was Fidelity International, exiting entirely with an estimated $11.9M sold.

  • 32 institutional investors held AC Immune (ACIU) as of Q3 2018, up from 15 in Q2 2018.
  • Funds reported $153M of AC Immune stock for Q3 2018, up 50% quarter-over-quarter.
  • 18 funds opened new AC Immune positions in Q3 2018 and 1 closed out, a net change of +17 holders.
  • The largest AC Immune buyer in Q3 2018 was BVF Inc, an estimated $20.3M added.
  • The largest AC Immune seller in Q3 2018 was Fidelity International, an estimated $11.9M sold.

Based on aggregated 13F filings for Q3 2018.